UBS made no change to the firm’s Neutral rating or $132 price target on Clorox. The firm came away from Clorox’s sell-side management meeting with increased conviction the recovery is playing out as expected, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on CLX:
- Baidu upgraded, Foot Locker downgraded: Wall Street’s top analyst calls
- Clorox upgraded to Neutral from Underweight at JPMorgan
- Clorox price target raised to $162 from $152 at DA Davidson
- Clorox board elects CEO Linda Rendle to the role of chair
- Clorox participates in a conference call with DA Davidson